CME Group
CME GROUP INC.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$6.5B
Operating marginCalculated
64.9%
Net assets to total assetsCalculated
14.5%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★★position among all companies
64.9%
Growth (revenue, 4-year average)
★★★☆☆position among all companies
8.6%
Capital efficiency
★★★★☆position among all companies
14.2%
Revenue and profit
Performance, financial position and capital allocation
CME Group
Recent performance trends
CME Group
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$4.7 billion | US$5.0 billion | US$5.6 billion | US$6.1 billion | US$6.5 billion |
| Operating income | US$2.6 billion | US$3.0 billion | US$3.4 billion | US$3.9 billion | US$4.2 billion |
| Net income | US$2.6 billion | US$2.7 billion | US$3.2 billion | US$3.5 billion | US$4.1 billion |
| Total assets | US$196.8 billion | US$174.2 billion | US$129.7 billion | US$137.4 billion | US$198.4 billion |
| Shareholders' equity | US$27.4 billion | US$26.9 billion | US$26.7 billion | US$26.5 billion | US$28.7 billion |
| Net cash provided by (used in) operating activities | US$2.4 billion | US$3.1 billion | US$3.5 billion | US$3.7 billion | US$4.3 billion |
| Net cash provided by (used in) investing activities | US$58.40 million | US$-0.5 billion | US$20.90 million | US$-82.60 million | US$1.5 billion |
| Net cash provided by (used in) financing activities | US$69.9 billion | US$-25.4 billion | US$-48.3 billion | US$5.1 billion | US$56.5 billion |
| Cash and cash equivalents | US$2.8 billion | US$2.7 billion | US$2.9 billion | US$2.9 billion | US$4.4 billion |
Revenue scale in the same industry
CME Group
Securities and commodity brokers: 32 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 StoneX GroupFY Sep 2025 US$132.4B
- 2 Morgan StanleyFY Dec 2025 US$70.6B
- 3 Galaxy DigitalFY Dec 2025 US$60.4B
- … 13 companies
- 17 NasdaqFY Dec 2025 US$8.3B
- 18 Price T Rowe GroupFY Dec 2025 US$7.3B
- 19 CME GroupThis companyFY Dec 2025 US$6.5B
- 20 InvescoFY Dec 2025 US$6.4B
- 21 Stifel FinancialFY Dec 2025 US$6.3B
- … 11 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$83.50 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$4.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$56.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$1.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$4.3 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.1 billion | Consolidated | Disclosed |
| Dividends paid | US$3.9 billion | Consolidated | Disclosed |
| Net assets | US$28.7 billion | Consolidated | Disclosed |
| Net sales | US$6.5 billion | Consolidated | Disclosed |
| Operating income | US$4.2 billion | Consolidated | Disclosed |
| Net income | US$4.1 billion | Consolidated | Disclosed |
| Total assets | US$198.4 billion | Consolidated | Disclosed |
| Operating margin | 64.9% | Consolidated | Calculated |
| Net assets to total assets | 14.5% | Consolidated | Calculated |
| Net margin | 62.5% | Consolidated | Calculated |
| Return on equity | 14.2% | Consolidated | Calculated |